Main content

Mission & scope

Oncology Reviews aims to be the leading journal in the field by publishing open access premier reviews on preclinical and clinical aspects of oncology. The journal provides up-to-date information on the latest achievements in different fields of oncology for both practicing clinicians and basic researchers. Oncology Reviews aims at being international in both scope and readership, as reflected by its Editorial Board, gathering the world-leading experts in both pre-clinical research and everyday clinical practice.

Editorial Board

Oncology Reviews’ Advisory Board and Editorial Board provides strategic and professional advice to the Editors-in-Chief. The journal recognises the following Editorial Board and Advisory Board members for their continuous guidance and support of the journal:

Editor-in-Chief

Camillo Porta

Chair of Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari 'A. Moro', Chief, Division of Medical Oncology, Policlinico Consorziale di Bari, Piazza G. Cesare, 11, 70124 Bari, Italy. Tel.: +39-080-5594167 Email: camillo.porta@gmail.com

Assistant Editor-in-Chief

Carlo Ganini

University of Bari Aldo Moro, Italy

Advisory Editorial Board and Associate Editors

Daniel D. Billadeau, Department of Immunology and Division of Oncology Research, Schulze Center for Novel Therapeutics, College of Medicine, Mayo Clinic, Rochester, MN, USA

Marco Bregni, Medical Oncology Unit, Ospedale San Giuseppe; Department of Hematology, Istituto Scientifico San Raffaele, Milano, Italy

Ronald M. Bukowski, Experimental Therapeutics, Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA

Zhaolun Cai, West China Hospital, Sichuan University, China

Anna Capasso, Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, University of Texas at Austin, Austin, TX, USA

Marco Cives, University of Bari Aldo Moro, Italy

Ramon Andrade de Mello, Department of Medical Oncology, Portuguese Oncology Institute, Porto, Portugal

Giovanni Gaudino, Italian Mesothelioma Group, Gruppo Italiano Mesotelioma - GIMe, Pavia, Italy; Department of Chemical, Food, Pharmaceutical and Pharmacological Sciences and Drug and Food Biotechnology Center, University of Piemonte Orientale ‘A. Avogadro’, Novara, Italy

Deepa Kushwaha, Rare Genomics Institute/RareShare, Hanover, MD, USA

Luciano Mutti, Ospedale SS. Pietro e Paolo di Borgosesia, Borgosesia (VC), Italy; Italian Mesothelioma Group, Gruppo Italiano Mesotelioma - GIMe, Pavia, Italy

Mimma Rizzo, Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Italy

Giovanni Rosti, Department of Oncology and Hematology, Istituto Oncologico Romagnolo Ospedale Civile, Ravenna, Italy

Ugo Rovigatti, Department of Oncology, University of Pisa Medical School, Italy

Giorgio V. Scagliotti, Department of Clinical & Biological Sciences, Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Regione Gonzole, Orbassano (TO), Italy; Department of Clinical and Biological Sciences Thoracic Oncology UNIT, San Luigi Hospital, University of Turin, Orbassano (TO), Italy

To apply to the Editorial Board as Associate Editor or Review Editor, please email a CV and statement of interest to the Editorial Office at oncologyreviews.editorial.office@frontierspartnerships.org.

Journal Information

Short name

Oncol Rev.
Abbreviation

or
Electronic ISSN

1970-5557
Indexed in

CLOCKSS, DOAJ, EBSCO, PubMed, PubMed Central (PMC), SCImago (SJR), Scopus, Web of Science Emerging Sources Citation Index (ESCI)
PMCID

All published articles receive a PMCID
Impact

3.6 Impact Factor

7.8 CiteScore

Open Access Statement

Oncology Reviews is a free online Gold Open Access journal.

Open Access funder and institutional mandates: Oncology Reviews is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution licence (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Council (Australia) are fully compatible with publishing in Oncology Reviews. Authors retain copyright of their work and can deposit their publication in any repository. The work can be freely shared and adapted provided that appropriate credit is given and any changes specified.

Copyright Statement

Under the Conditions for Website Use and the General Conditions for Authors, authors of articles published in Oncology Reviews retain copyright on their articles, except for any third-party images and other materials added by Oncology Reviews, which are subject to copyright of their respective owners. Authors are therefore free to disseminate and re-publish their articles, subject to any requirements of third-party copyright owners and subject to the original publication being fully cited. Visitors may also download and forward articles subject to the citation requirements and subject to any fees Oncology Reviews’ publisher, Frontiers, may charge for downloading licenses. The ability to copy, download, forward or otherwise distribute any materials is always subject to any copyright notices displayed. Copyright notices must be displayed prominently and may not be obliterated, deleted or hidden, totally or partially.

Quality

Each Oncology Reviews article strives for the highest quality, thanks to genuinely collaborative interactions between authors, editors and reviewers. Oncology Reviews encourages authors to consult the instructions for authors guidelines before submission.

Contact

Editorial Office

Avenue du Tribunal Fédéral 34

CH – 1005 Lausanne

Switzerland

Tel +41(0)21 510 17 40

Fax +41 (0)21 510 17 01

For all queries regarding manuscripts in review, potential conflicts of interest, special issues, editorial board applications and any other questions, please contact us by emailing: oncologyreviews@frontiersin.org

IT HelpDesk

Tel +41(0)21 510 17 10